Results 111 to 120 of about 286,663 (309)
IL-20 is epigenetically regulated in NSCLC and down regulates the expression of VEGF
Background\ud \ud IL-20 is a pleiotrophic member of the IL-10 family and plays a role in skin biology and the development of haematopoietic cells. Recently, IL-20 has been demonstrated to have potential anti-angiogenic effects in non-small cell lung ...
Gray , Steven G. +5 more
core +1 more source
A spatial niche composed of BTLA+B cells and CD8+T cells is enriched at the tumor boundary in non‐small cell lung cancer. Within this specialized niche, BTLA+B cells act as a dominant source of IL‐6, upregulating PD‐1 on CD8+T cells via STAT3 signaling.
Jiajuan Wu +6 more
wiley +1 more source
Practical management of NSCLC patients with long-term bevacizumab treatment: a report of four cases
GJM Herder,1 H Codrington,2 CD Colder,3 JG Aerts4,51St Antonius Hospital, Nieuwegein, The Netherlands; 2Haga Hospital, The Hague, The Netherlands; 3St Jansdal Hospital, Harderwijk, The Netherlands; 4Amphia Hospital, Breda; 5Erasmus MC Rotterdam, The ...
Aerts JG +3 more
core
CIP2A mediates erlotinib-induced apoptosis in non-small cell lung cancer cells without EGFR mutation
Background: Epidermal growth factor receptor (EGFR) inhibitors show favorable clinical response in some patients with non-small cell lung cancer (NSCLC) who have no EGFR mutation, indicating alternative mechanisms for their tumoricidal effects.
余忠仁;陳昆鋒 +1 more
core +1 more source
Graphical illustration of 68Ga‐GZB PET/CT imaging reveals immune dynamics post‐EGFR‐TKI resistance in NSCLC; Lgmn+ macrophages‐derived Lgmn‐containing extracellular vesicles inhibit glycolysis, induce CD8+ T cell exhaustion, and targeting Lgmn restores immunotherapy sensitivity.
Dongliang Wang +9 more
wiley +1 more source
Xiaoliang Chen, Pingan Song, Yuan Yao, Yang Yang Department of Thoracic Surgery, Gansu Gem Flower Hospital, Lanzhou 730060, Gansu, People’s Republic of ChinaCorrespondence: Xiaoliang Chen Department of Thoracic SurgeryGansu Gem Flower Hospital, 733
Chen X, Song P, Yao Y, Yang Y
doaj
reservedBackground: Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related death worldwide. Diverse treatment approaches are accessible, and neoadjuvant therapy holds potential to enhance survival rates and elevate curative ...
BUFFON, LAURA
core
CYYR1 as an epigenetically dysregulated tumor‐suppressive factor that influences oncoprotein stability through TRIM21‐dependent HMMR regulation and reveals a potential therapeutic vulnerability in CYYR1‐deficient LUAD. The graphical illustration was created using FigDraw (www.figdraw.com).
Fengsheng Dai +15 more
wiley +1 more source
Lanxiang Bai1 ,* Xiaonu Peng2 ,* Ruimei Sun3 1Disinfection Supply Center, Yantai Yuhuangding Hospital, Yantai 264000, Shandong, People’s Republic of China; 2Department of Thoracic Surgery, Yantai Yuhuangding Hospital, Yantai 264000, Shandong ...
Bai L, Peng X, Sun R
doaj
Mutation prevalence in NCT00890825 NSCLC patients using MALDI-TOF panel compared to COSMIC NSCLC database.
Jill Walker (582088) +4 more
core +1 more source

